1760 Stock Overview
A biotechnology pharmaceutical company, provides western medicines, cosmetics, and health care products in Taiwan, the United States, China, Hong Kong, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Panion & Bf Biotech Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$83.30 |
52 Week High | NT$115.00 |
52 Week Low | NT$76.20 |
Beta | 0.25 |
1 Month Change | -3.36% |
3 Month Change | -6.09% |
1 Year Change | -20.67% |
3 Year Change | 2.33% |
5 Year Change | -3.03% |
Change since IPO | 635.50% |
Recent News & Updates
Recent updates
Is Panion & Bf Biotech (TWSE:1760) A Risky Investment?
Aug 13Here's Why Panion & Bf Biotech (TPE:1760) Has A Meaningful Debt Burden
Apr 07Is Panion & Bf Biotech Inc. (TPE:1760) A Strong Dividend Stock?
Mar 03Introducing Panion & Bf Biotech (TPE:1760), A Stock That Climbed 47% In The Last Three Years
Feb 04Are Panion & Bf Biotech Inc.'s (TPE:1760) Mixed Financials Driving The Negative Sentiment?
Jan 09Panion & Bf Biotech (TPE:1760) Has A Somewhat Strained Balance Sheet
Dec 14Shareholder Returns
1760 | TW Pharmaceuticals | TW Market | |
---|---|---|---|
7D | 1.5% | -0.1% | 2.5% |
1Y | -20.7% | 1.6% | 32.2% |
Return vs Industry: 1760 underperformed the TW Pharmaceuticals industry which returned 1.6% over the past year.
Return vs Market: 1760 underperformed the TW Market which returned 32.2% over the past year.
Price Volatility
1760 volatility | |
---|---|
1760 Average Weekly Movement | 3.1% |
Pharmaceuticals Industry Average Movement | 3.7% |
Market Average Movement | 4.4% |
10% most volatile stocks in TW Market | 7.8% |
10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 1760 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 1760's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1974 | n/a | Tsung-Ming Chiang | www.pbf.com.tw |
Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, and health care products in Taiwan, the United States, China, Hong Kong, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, Covid-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygiene services.
Panion & Bf Biotech Inc. Fundamentals Summary
1760 fundamental statistics | |
---|---|
Market cap | NT$7.04b |
Earnings (TTM) | NT$121.33m |
Revenue (TTM) | NT$2.04b |
58.9x
P/E Ratio3.5x
P/S RatioIs 1760 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
1760 income statement (TTM) | |
---|---|
Revenue | NT$2.04b |
Cost of Revenue | NT$968.40m |
Gross Profit | NT$1.07b |
Other Expenses | NT$946.04m |
Earnings | NT$121.33m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.42 |
Gross Margin | 52.43% |
Net Profit Margin | 5.96% |
Debt/Equity Ratio | 36.8% |
How did 1760 perform over the long term?
See historical performance and comparisonDividends
1.8%
Current Dividend Yield106%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/08 07:54 |
End of Day Share Price | 2025/01/08 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Panion & Bf Biotech Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jianzheng Wu | Capital Securities Corporation |
Xiaowei Huang | Masterlink Securities Corp. |
Jane Jiang | Yuanta Research |